Which basal insulin should be used in patients with type 2 diabetes mellitus?

被引:6
|
作者
Clore J.N. [1 ]
Thurby-Hay L. [1 ]
机构
[1] Division of Endocrinology and Metabolism, Virginia Commonwealth University, Richmond, VA 23298
关键词
Insulin Glargine; Basal Insulin; Insulin Lispro; Insulin Detemir; Endogenous Glucose Production;
D O I
10.1007/s11892-007-0057-8
中图分类号
学科分类号
摘要
The initiation of insulin therapy is a significant event for patients with diabetes and the physicians who care for them. Reluctance to begin insulin is multifactorial, with major stumbling blocks being the perceived complexity of insulin and fear of hypoglycemia. Recent guidelines supporting earlier introduction of insulin to achieve glycemic goals in patients with type 2 diabetes mellitus will require that traditional approaches to insulin therapy be altered and a new paradigm be introduced into clinical practice. In particular, an understanding of the role of basal insulin in the regulation of glucose and the development of strategies to implement basal insulin therapy can provide a transition that is rational and highly effective in most patients. The strategy also offers a unique approach to diabetes education that permits a focused and patient-specific correction to glucose abnormalities. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:348 / 352
页数:4
相关论文
共 50 条
  • [1] Basal insulin requirement in insulin treated patients with type 2 diabetes mellitus
    Wiesli, P
    Lehmann, R
    Kraydenbühl, PA
    Schmid, C
    Spinas, GA
    DIABETES, 2005, 54 : A102 - A102
  • [2] Initiating basal insulin therapy in patients with type 2 diabetes mellitus
    Stoneking, K
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 510 - 518
  • [3] Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin
    Blak, B. T.
    Smith, H. T.
    Hards, M.
    Curtis, B. H.
    Ivanyi, T.
    DIABETIC MEDICINE, 2012, 29 (07) : E13 - E20
  • [4] Lipoprotein (a) is Associated with Basal Insulin Levels in Patients with Type 2 Diabetes Mellitus
    Habib, Syed Shahid
    Aslam, Muhammad
    Shah, Syed Fayaz Ahmad
    Naveed, Abdul Khaliq
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2009, 93 (01) : 28 - 33
  • [5] Update on Basal Insulin Therapy for Type 2 Diabetes Mellitus
    Patel, Hansita B.
    Witte, Amy P.
    US PHARMACIST, 2021, 46 (11) : 44 - 50
  • [6] Expanded Basal Insulin Options for Type 2 Diabetes Mellitus
    Olin, Jacqueline L.
    Harris, Kira B.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2017, 13 (03): : 210 - 215
  • [7] Intensification of Basal Insulin Treatment Among Patients with Type 2 Diabetes Mellitus in the Netherlands
    Overbeek, Jetty A.
    Houben, Eline
    Kring, Sofia I.
    Briers, Jonathan
    Beest, Fernie J. A. Penning-van
    Van der Heijden, Amber A. W. A.
    Nijpels, Giel
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 77 - 77
  • [8] INTENSIFICATION OF BASAL INSULIN TREATMENT AMONG PATIENTS WITH DIABETES MELLITUS TYPE 2 IN THE NETHERLANDS
    Overbeek, J.
    Houben, E.
    Kring, S.
    Sommer, J.
    Penning-van Beest, F.
    van der Heijden, A.
    Nijpels, G.
    Herings, R.
    VALUE IN HEALTH, 2015, 18 (07) : A617 - A617
  • [9] A STEPWISE APPROACH TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND BASAL INSULIN TREATMENT FAILURE
    Davidson, Mayer B.
    Raskin, Philip
    Tanenberg, Robert J.
    Vlajnic, Aleksandra
    Hollander, Pricilla
    ENDOCRINE PRACTICE, 2011, 17 (03) : 395 - 403
  • [10] Basal Insulin Resistance and Secretion in Nigerians With Type 2 Diabetes Mellitus
    Oli, J. M.
    Adeyemo, A. A.
    Okafor, G. O.
    Ofoegbu, E. N.
    Onyenekwe, B.
    Chukwuka, C. J.
    Onwasigwe, C. N.
    Ufelle, S.
    Chen, G.
    Rotimi, C. N.
    METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (06) : 595 - 599